Preprint or it didn't happen. [I'd like to ask for a accepted article in a serious peer review journal, but it's too much.]
From the subtitles, the recommendation is based in the difference in mortality in countries in Africa that give ivermectin to everyone regularly and those who don't. Last time someone posted two preprints about the subject https://news.ycombinator.com/item?id=27789555 , after reading them my conclusion was that the two groups of countries are very different. The countries that use ivermectin have a average life expectation of 60 years, and the other countries average of 66. So they are very different countries. The life expectancy is related to many things, like the quality of the hospitals and the number of very old people that has more risk with covid-19, so it's very difficult to compare them.
Preprint or it didn't happen. [I'd like to ask for a accepted article in a serious peer review journal, but it's too much.]
From the subtitles, the recommendation is based in the difference in mortality in countries in Africa that give ivermectin to everyone regularly and those who don't. Last time someone posted two preprints about the subject https://news.ycombinator.com/item?id=27789555 , after reading them my conclusion was that the two groups of countries are very different. The countries that use ivermectin have a average life expectation of 60 years, and the other countries average of 66. So they are very different countries. The life expectancy is related to many things, like the quality of the hospitals and the number of very old people that has more risk with covid-19, so it's very difficult to compare them.